Gradual implementation of first trimester screening in a population with a prior screening strategy: population based

Pavel Calda1, Antonín Sípek, Vladimír Gregor

  • 1Department of Obstetrics and Gynecology of the First Faculty of Medicine and General University Hospital, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. calda@gynstart.cz

Insights

First trimester screening in the Czech Republic reduced newborn Down's syndrome cases despite rising maternal age. This screening improved early diagnosis rates for chromosomal abnormalities.

Area of Science:

  • Prenatal diagnostics and genetic screening
  • Reproductive health and obstetrics
  • Public health policy and implementation

Background:

  • The Czech Republic implemented first trimester screening between 1996 and 2007.
  • This period saw an increase in maternal age, a known risk factor for chromosomal anomalies.
  • Understanding the impact of screening on diagnostic rates and invasive procedures is crucial.

Purpose of the Study:

  • To evaluate the effectiveness of first trimester screening implementation in the Czech Republic.
  • To assess changes in the incidence of numerical chromosomal anomalies, particularly Down's syndrome.
  • To analyze gestational age at diagnosis and the rates of invasive diagnostic procedures like CVS and amniocentesis.

Main Methods:

  • A population-based cohort study was conducted.
  • Data were sourced from the National Registry of Congenital Anomalies and 53 genetic departments.
  • Approximately 100,000 pregnancies per year were analyzed over the study period.

Main Results:

  • Newborns with Down's syndrome decreased from 5.42 to 3.66 per 10,000 births between 1996 and 2007.
  • Detection rates for Down's syndrome increased in both younger (<35 years) and older (>35 years) maternal age groups.
  • The number of amniocenteses per detected Down's syndrome case remained stable, while chorionic villus sampling (CVS) decreased significantly.

Conclusions:

  • First trimester screening successfully reduced the number of newborns with Down's syndrome, even with increasing maternal age.
  • The implementation led to earlier diagnoses of major chromosomal abnormalities.
  • Screening strategies effectively shifted diagnostic procedures towards earlier detection.
Abstract